Скачать или смотреть Upadacitinib for Atopic Dermatitis: Real-World Results on Itch, Skin Clearance, and Quality of Life

Discover the real-world effectiveness of upadacitinib (Rinvoq) in treating moderate-to-severe atopic dermatitis. This video explores the SCALE-UP study presented at the 2025 Fall Clinical Dermatology Conference, revealing rapid improvements in itch, skin clearance, sleep, and overall quality of life for patients, regardless of prior advanced systemic therapy use. Learn about the impact of upadacitinib on both treatment-naive and treatment-experienced individuals with atopic dermatitis.
Key takeaways from the SCALE-UP study:
Significant improvements in itch and skin clearance with upadacitinib.
Rapid relief from atopic dermatitis symptoms reported by patients.
Enhanced sleep quality and improved Dermatology Life Quality Index (DLQI) scores.
Consistent benefits observed in both AST-naïve and AST-experienced patients.